-
- Press releases
- MedImpact's Steven Avey receives AMCP Foundation's highest award
- Avey honored for groundbreaking work that has improved countless lives, changed pharmacy benefit management
- READ MORE
-
- Client news
- Paying for cures
- MedImpact sponsors MIT initiative to help make high-cost curative therapies more accessible
- READ MORE
-
- Client news
- Combating the opioid crisis together
- MedImpact helps reduce opioid utilization in one of America's most affected states
- READ MORE
-
- Client news
- MedImpact activates natural disaster response in wake of Hurricane Michael
- As Hurricane Michael — the strongest hurricane in history to hit the Florida Panhandle — continues to surge through the Southeast with damaging winds and flood-causing rains, MedImpact is committed to providing natural disaster support to our clients and members.
- READ MORE
-
- Client news
- FDA approves new preventive treatment for rare hereditary disease
- The U.S. Food and Drug Administration (FDA) recently approved Takhzyro (lanadelumab-flyo) as the first preventive monoclonal antibody to treat hereditary angioedema (HAE) to help prevent attacks in patients 12 years and older. HAE is a rare and potentially life-threatening genetic disease that can cause unpredictable, debilitating episodes of painful swelling in the limbs, abdomen and airway.
- READ MORE
-
- Client news
- Moving toward performance-based networks
- MedImpact discusses trends in value-based pharmacy reimbursement in Chain Drugstore Daily
- READ MORE
We are the PBM that puts clients and consumers first. Always. Ready for a change?
